Literature DB >> 25196364

High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumors.

Ana M Ferreira1, Iina Tuominen, Krista van Dijk-Bos, Bahram Sanjabi, Tineke van der Sluis, Ate G van der Zee, Harry Hollema, Monika Zazula, Rolf H Sijmons, Lauri A Aaltonen, Helga Westers, Robert M W Hofstra.   

Abstract

Ribosomal Protein L22 (RPL22) encodes a protein that is a component of the 60S subunit of the ribosome. Variants in this gene have recently been linked to cancer development. Mutations in an A8 repeat in exon 2 were found in a recent study in 52% of microsatellite-unstable endometrial tumors. These tumors are particularly prone to mutations in repeats due to mismatch repair deficiency. We screened this coding repeat in our collection of microsatellite-unstable endometrial tumors (EC) and colorectal tumors (CRC). We found 50% mutation frequency for EC and 77% mutation frequency for CRC. These results confirm the previous study on the involvement of RPL22 in EC and, more importantly, reports for the first time such high mutation frequency in this gene in colorectal cancer. Furthermore, considering the high mutation frequency found, our data point toward an important role for RPL22 in microsatellite instability carcinogenesis.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  RPL22; colorectal cancer; endometrial cancer; microsatellite instability; target gene

Mesh:

Substances:

Year:  2014        PMID: 25196364     DOI: 10.1002/humu.22686

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  26 in total

1.  Intratumoral Heterogeneity of RPL22 Frameshift Mutation in Colorectal Cancers.

Authors:  Ju Hwa Lee; Chang Hyeok An; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2018-06-02       Impact factor: 3.201

Review 2.  Acquired ribosomopathies in leukemia and solid tumors.

Authors:  Adrianna Vlachos
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.

Authors:  Neylen Del Toro; Ana Fernandez-Ruiz; Lian Mignacca; Paloma Kalegari; Marie-Camille Rowell; Sebastian Igelmann; Emmanuelle Saint-Germain; Mehdi Benfdil; Stéphane Lopes-Paciencia; Léa Brakier-Gingras; Véronique Bourdeau; Gerardo Ferbeyre; Frédéric Lessard
Journal:  Cell Cycle       Date:  2019-03-28       Impact factor: 4.534

4.  Identification of RPL5 gene variants and the risk of hepatic vein thrombosis in Saudi patients.

Authors:  Fathelrahman M Hassan; Afnan A Alsultan; Faisal Alzahrani; Waleed H Albuali; Dalal K Bubshait; Elfadil M Abass; Mudathir A Elbasheer; Abdulmohsen A Alkhanbashi
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

5.  Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.

Authors:  Shuyun Rao; Kathy Q Cai; Jason E Stadanlick; Noa Greenberg-Kushnir; Nehal Solanki-Patel; Sang-Yun Lee; Shawn P Fahl; Joseph R Testa; David L Wiest
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

Review 6.  Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.

Authors:  Byungho Lim; Jong-Hwan Kim; Mirang Kim; Seon-Young Kim
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  Expansion of germline RPS20 mutation phenotype to include Diamond-Blackfan anemia.

Authors:  Saleh Bhar; Fujun Zhou; Lucas C Reineke; Danna K Morris; Payal P Khincha; Neelam Giri; Lisa Mirabello; Katie Bergstrom; Laramie D Lemon; Christopher L Williams; Yukimatsu Toh; M Tarek Elghetany; Richard E Lloyd; Blanche P Alter; Sharon A Savage; Alison A Bertuch
Journal:  Hum Mutat       Date:  2020-08-30       Impact factor: 4.878

Review 8.  Role of ribosomal protein mutations in tumor development (Review).

Authors:  Kaveh M Goudarzi; Mikael S Lindström
Journal:  Int J Oncol       Date:  2016-02-09       Impact factor: 5.650

9.  Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.

Authors:  Shahida Din; Kim Wong; Mike F Mueller; Anca Oniscu; James Hewinson; Catherine J Black; Martin L Miller; Alejandro Jiménez-Sánchez; Roy Rabbie; Mamunar Rashid; Jack Satsangi; David J Adams; Mark J Arends
Journal:  Clin Cancer Res       Date:  2018-06-27       Impact factor: 12.531

Review 10.  How Ribosomes Translate Cancer.

Authors:  Sergey O Sulima; Isabel J F Hofman; Kim De Keersmaecker; Jonathan D Dinman
Journal:  Cancer Discov       Date:  2017-09-18       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.